image
Replimune Group, Inc. REPL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.765
9.63 %
$ 675 M
Market Cap
-2.86
P/E
Price Target Average
105.36%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
20.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Replimune Group, Inc.
image
Wall Street analysts predict an average 1-year price target for REPL of $18 , with forecasts ranging from a low of $13 to a high of $27 .
REPL Lowest Price Target Wall Street Target
13 USD 48.32%
REPL Average Price Target Wall Street Target
18 USD 105.36%
REPL Highest Price Target Wall Street Target
27 USD 208.04%
Price
Max Price Target
Min Price Target
Average Price Target
3030252520201515101055May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart REPL

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart REPL

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart REPL

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)202420242025202520262026202720272028202820292029